eli lilly - Search News

News

type 2 diabetes, Lilly and Mounjaro

Mounjaro appears more heart protective than Trulicity in trial of Eli Lilly diabetes drugs

Eli Lilly said on Thursday that its newer diabetes drug Mounjaro outperformed Trulicity, its previously top-selling medication for the disease, in reducing the risk of heart attack and stroke in a large,

CNBC on MSN · 15h

Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity

Eli Lilly said it believes the new data bolsters the case for Mounjaro to be prescribers' first choice for patients with Type 2 diabetes.

STAT · 14h

Lilly’s diabetes drug Mounjaro matches heart benefit of older treatment

Eli Lilly’s blockbuster diabetes drug Mounjaro matched the ability of an older treatment to prevent major heart complications in a large trial.

Trump, drug price and Eli Lilly & Co

Bloomberg on MSN · 7h

Trump Demands Largest Pharma Companies Slash US Drug Prices

President Donald Trump sent letters to 17 of the world’s largest pharmaceutical companies — including Eli Lilly & Co., Novo Nordisk A/S and Pfizer Inc. — insisting they slash their US prices on new drugs to the lowest amount paid by certain other countries.

Newsweek on MSN · 7h

Trump sets deadline on drug price demand in letter to companies

President Donald Trump sent a letter to 17 drug companies demanding a commitment to bring down prices in the next 60 days through a series of initiatives.

MarketWatch · 8h

Eli Lilly’s stock drops as Trump targets 17 drug makers with letters on their pricing

Shares of Eli Lilly & Co. erased gains to trade down nearly 1% after White House press secretary Karoline Leavitt said the company was among 17 drugmakers that will be receiving letters from President Donald Trump over their pricing practices.

Fierce Pharma13h

Lilly's Mounjaro shows its cardio benefits in Trulicity head-to-head trial

A variety of GLP-1 drugs that were developed to treat Type 2 diabetes, including Novo Nordisk’s Ozempic, have secured label ...

2don MSN

Lilly set for strong quarter after Novo profit warning

Investors and analysts say they expect Eli Lilly to report stronger quarterly sales and profit next week than Danish rival ...

BioSpace10h

Lilly’s Mounjaro ‘Good Enough’ in Cardio Trial, Will Seek Expanded Approval

While Eli Lilly’s diabetes blockbuster was non-inferior to its older incretin therapy Trulicity in a highly anticipated Phase III cardiovascular outcomes trial, analysts had hoped for statistical ...

What's Going On With Eli Lilly Stock On Tuesday?

Eli Lilly stock slips after Novo Nordisk trims 2025 forecast; Jaypirca meets endpoint in CLL trial against J&J's Imbruvica, ...

2don MSN

Lilly's cancer drug more effective than AbbVie's in head-to-head study

Eli Lilly said on Tuesday its drug for a type of blood cancer was more effective in a head-to-head study against AbbVie's ...

Eli Lilly Weight-Loss Drug Makes Cardio Advance. More Bad News for Novo Nordisk.

Eli Lilly drug Mounjaro resulted in a lower risk of heart attacks and strokes in patients with diabetes compared with the ...

Eli Lilly and Company (LLY): We Sold Some Lilly, Says Jim Cramer

We recently published 12 Stocks Jim Cramer Recently Discussed As He Commented On A “Sea Of Green”. Eli Lilly and Company ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results